Newsroom

Press Releases

Davide Molho, DVM

Press Release

Davide Molho, DVM, Life Sciences Industry Veteran joins BioAgilytix as CEO

BioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical laboratory, today announced the appointment of Davide Molho, DVM, as its new Chief Executive Officer (CEO) with…

Press Release

A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA

A3P Biomedical AB, a Swedish company specialized in advanced prostate cancer diagnostics, and BioAgilytix, a global bioanalytical services provider, have entered a partnership with the…

Press Release

BioAgilytix Commits to United Nations Global Compact

Leading bioanalytical services provider pledges to act in support of human rights and environmental sustainability. DURHAM, NC, August 1, 2023 – BioAgilytix Labs, LLC (BioAgilytix),…

Press Release

BioAgilytix Expands Hamburg Lab to Support Customer Drug Development from Early Phase to Market Authorization

PCR platforms and Good Manufacturing Practices (GMP) certification further enhance European service offerings HAMBURG, GERMANY and DURHAM, NC, May 8, 2023/EINPresswire.com/ BioAgilytix Labs, LLC (BioAgilytix),…

Media Coverage

Media Coverage

Pre-existing Immunogenicity: How Will Cell and Gene Therapies Change Our Testing Approach?

In this article, Chief Scientific Officer at BioAgilytix, Jim McNally, Ph.D., explores why bioanalysts should prepare for the impending wave of C&GTs entering the development…

Media Coverage

Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter…

Media Coverage

Trends Paving The Way For An Influx Of Biosimilar Development

Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With many patents for blockbuster” commercial…